2017 Symposium

Infectious Disease Symposium

2017 Symposium

Speakers and Chairs at 2nd Symposium on Infectious Diseases in the Immunocompromised Host, June 19-20, 2017.

Speaker Dr. John Zaia, City of Hope

Some of the 48 travel stipend recipients, from 38 medical schools and cancer centers, who received travel stipends to attend the symposium. They were selected after a competitive review process.

All photos by Robert Hood / Fred Hutch News Service


In 2017, our 2nd Symposium on Infectious Diseases in the Immunocompromised Host grew to a 2-day event with an expanded audience, increased trainee participation, and a broader range of critically relevant topics. More than 30 esteemed speakers provided their expertise as leaders in the field and gave our audience a chance to celebrate significant accomplishments in the field of infectious disease in the immunocompromised host. Forty-eight trainees were able to attend the symposium as part of our expanded travel stipend program. 

The marked growth of our 2nd Symposium since our inaugural event in 2016 speaks to clinicians’ and researchers’ strengthening commitment to the detection, prevention and treatment of infectious diseases, and ever-increasing understanding of the need to mitigate serious complications in immunocompromised individuals. 

Our thanks to the following sponsors for their generous support of the 2nd Symposium on Infectious Diseases in the Immunocompromised Host:

  • The Vaccine and Infectious Disease Division at Fred Hutchinson Cancer Research Center
  • Chimerix, Inc.
  • Oxford Immunotec
  • Ansun Biopharma
  • Karius, Inc.

2017 Speakers and Topics:

Introduction
Michael Boeckh | Fred Hutchinson Cancer Research Center, University of Washington

Keynote Address
Vaccine and Monoclonal Antibodies for CMV Prevention in Transplant Recipients
Paul Griffiths | University College London Medical School
 

VACCINE AND IMMUNOTHERAPY
CHAIR: Lawrence Corey | Fred Hutchinson Cancer Research Center; University of Washington

Immunologic Control of CMV in Transplantation 
John Zaia | City of Hope National Medical Center

Adoptive T Cell Therapy for Viral Infections
Ann Leen | Baylor College of Medicine

Infections Following CAR T Cell Therapy
Joshua Hill | Fred Hutchinson Cancer Research Center, University of Washington
 

FUNGAL INFECTIONS
CHAIR: Kieren Marr | Johns Hopkins University School of Medicine

Candida Infections in the Immunocompromised Host
William Steinbach | Duke University Medical Center

Genetic susceptibility for invasive aspergillosis
Tobias Hohl | Memorial Sloan Kettering Cancer Center

Novel Diagnostic Approaches to the Diagnosis of Invasive Aspergillosis
Sophia Koo Brigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School

Pro and Con Debate
Upfront Combination Antifungal Therapy: Pro/Con
Moderators: Catherine Liu | Fred Hutchinson Cancer Research Center, University of Washington, Seattle Cancer Care Alliance and Joshua Schiffer | Fred Hutchinson Cancer Research Center, University of Washington

  • Dimitrios Kontoyiannis | The University of Texas MD Anderson Cancer Center
  • Kieren Marr | Johns Hopkins University School of Medicine
     

MICROBIOME
CHAIR: David N. Fredricks | Fred Hutchinson Cancer Research Center; University of Washington

Microbiome in Transplantation
Ying Taur | Memorial Sloan Kettering Cancer Center

Gut Microbiome and GVHD
Jonathan Golob | Fred Hutchinson Cancer Research Center, University of Washington

Microbiome in Idiopathic Syndromes after Transplantation 
Ami Bhatt | Stanford University School of Medicine

Lung Microbiome in Lung Transplantation
Ronald Collman | University of Pennsylvania School of Medicine
 

FROM ADENOVIRUS TO ZIKA
CHAIR: Steven Pergam | Fred Hutchinson Cancer Research Center;University of Washington; Seattle Cancer Care Alliance

Adenovirus Impact and Therapeutic Options
Janet Englund | Seattle Children's Hospital, University of Washington

HIV Infection and Transplantation
Christine Durand | Johns Hopkins School of Medicine

Zika Virus Infections in Immunocompromised Patients
Clarisse Machado | Universidade de São Paulo, Brazil
 

RESPIRATORY VIRUSES
CHAIRS: Janet A. Englund | Seattle Children’s Hospital; University of Washington; Fred Hutchinson Cancer Research Center
Per Ljungman | Karolinska University Hospital; Karolinska Institutet, Stockholm, Sweden

RSV and Parainfluenzavirus Infections in HCT Recipients
Roy Chemaly | The University of Texas MD Anderson Cancer Center

Rhinovirus in HCT Recipients
Alpana Waghmare | Seattle Children's Hospital, University of Washington, Fred Hutchinson Cancer Research Center

Respiratory Virus Infections in SOT Recipients
Deepali Kumar | University of Toronto

Respiratory Virus Infections in Chronic Allograft Dysfunction
Ajit Limaye | University of Washington

Panel Discussion
Challenges in Identifying Novel Clinical Endpoints for the Development of Therapeutics for Respiratory Virus infections in Immunocompromised Patients
Moderator: Per Ljungman | Karolinska University Hospital; Karolinska Institutet
Panelists:

  • Roy Chemaly | The University of Texas MD Anderson Cancer Center
  • Francisco Marty | Brigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School
  • Michael Boeckh | Fred Hutchinson Cancer Research Center, University of Washington
  • Kieren Marr | Johns Hopkins University School of Medicine
     

ORIGINAL SHORT PRESENTATIONS BY TRAINEES
CHAIRS: Julie McElrath, Fred Hutchinson Cancer Research Center; University of Washington
Anna Wald, University of Washington; Fred Hutchinson Cancer Research Center

Therapeutic Drug Monitoring of Novel Formulations of Posaconazole in SOT Recipients
Ghady Haidar | University of Pittsburgh Medical Center

Performance of Targeted Fungal Sequencing for Culture-Independent Diagnosis of Invasive Fungal Disease
Carlos A. Gomez | Stanford University School of Medicine

Adoptive T Cell Therapy For HIV
Shabnum Patel | The George Washington University

Characterizing Monoclonal Antibodies Against Carbapenem-Resistant Klebsiella Pneumoniae
Elizabeth Diago-Navarro | Stony Brook University

Clinical Experience with Novel Cephalosporin/Beta-Lactamase Inhibitor Combinations in Solid Organ Transplant Recipients
Puja Nambiar | Cleveland Clinic

Chronic High EBV Load and T Cell Exhaustion in Pediatric Solid Organ Transplantation
Masaki Yamada | Children’s Hospital Pittsburgh
 

CYTOMEGALOVIRUS
CHAIRS: Michael Boeckh | Fred Hutchinson Cancer Research Center; University of Washington
Ajit Limaye | University of Washington; Fred Hutchinson Cancer Research Center

Prevention of CMV in SOT Recipients
Deepali Kumar | University of Toronto

Multivirus Infections
Joshua Schiffer | Fred Hutchinson Cancer Research Center, University of Washington

Antivirals to Prevent CMV in HCT
Francisco Marty | Brigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School
 

CLOSING REMARKS AND CONCLUSION
Michael Boeckh | Fred Hutchinson Cancer Research Center, University of Washington